Veralto Beats Consensus, But Insiders Selling
Veralto beat consensus earnings for the fourth consecutive quarter, with Q3 EPS of $1.18 beating estimates by 7.27%. Yet five executives including both segment heads sold $6.64M in shares post-earning
VLTO Analyst Target Outpaces Insider Conviction
NEW YORK, November 14 —
Veralto Corporation (VLTO) has beaten the Wall Street EPS consensus four quarters running, most recently by 7.27% on October 29, while five executives including both segment heads sold $6.64 million in shares in the weeks surrounding that report, with zero open-market purchases across all of them.
- Q3 adjusted EPS of $1.18 beat consensus by 7.27%; revenue of $1.51B topped estimates by 0.71% (per Zacks).
- Net insider sales of $6.64M across five executives in the 90 days ending mid-November 2026; zero open-market purchases.
The Compounder Case Is Legitimate
Veralto makes water quality instruments (Hach, Trojan Technologies, ChemTreat) for municipal utilities and industrial operations, plus product marking systems (Videojet, Linx), color management tools (X-Rite, Pantone), and packaging design software (Esko) for food, pharma, and industrial customers. Q3 revenue grew to $1.51B from $1.40B a year earlier, with adjusted EPS rising from $0.99 to $1.18. Trailing gross margins of 59.8% and $763M in free cash flow show the pricing power of proprietary instruments with long replacement cycles. At 24.4x forward earnings, that is exactly what the multiple pays for; test the implied valuation at the DCF calculator.
Five Sellers, Zero Buyers
What complicates that case: CEO Jennifer Honeycutt sold 7,098 shares at $105.00 six days before earnings; SVP Strategy Surekha Trivedi sold $3.97M the day after the report; SVP PQI Mattias Bystrom sold 9,069 shares at $116.28, $116.34 on November 3; SVP Water Quality Melissa Kapity sold at $118.06 on November 10, the highest price in the log. Every transaction followed the same exercise-and-sell structure, with option strikes ranging from $28.76 to $83.23, all well below market. That both segment heads, with direct visibility into forward divisional revenue, treated the post-earnings window as the moment to exit matters independent of method.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| VLTO | $28.8B | 24.2x | +20.6% |
| RVTY | $17.2B | 25.9x | +69.5% |
| FTV | $20.2B | 20.4x | +34.4% |
| EG | $15.8B | 7.0x | +33.4% |
| CPAY | $29.6B | 14.5x | +68.6% |
| BALL | $17.0B | 14.6x | +37.8% |
Q4 Is When This Gets Decided
At $118.25, VLTO has returned 3% year-to-date against the S&P 500's 13.1%, a gap four consecutive beats have not closed. The balance sheet is not the constraint: $1.78B in cash against $3.12B in debt leaves room for buybacks or bolt-ons. Q4 revenue guidance is the decisive number, the first data point from segment heads who just sold. Run the Veralto Corporation deep-dive to test the assumptions before the next earnings print.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Did Veralto beat earnings expectations?
Yes. Veralto beat Wall Street EPS consensus by 7.27% in Q3 2026, with adjusted EPS of $1.18. Q3 revenue of $1.51B also topped estimates by 0.71% — the company's fourth straight beat.
Are Veralto executives buying or selling stock?
Five executives including both segment heads sold $6.64M in shares in the 90 days ending mid-November 2026. CEO Jennifer Honeycutt sold 7,098 shares at $105 six days before earnings, and there were zero open-market purchases across all executives.
What is Veralto's analyst price target?
The analyst consensus target is $124.625, implying 5.4% upside from the current price of $118.25. Four straight beats have not closed the gap: VLTO has returned 3% year-to-date against the S&P 500's 13.1% gain.
What does Veralto make?
Veralto makes water quality instruments (Hach, Trojan Technologies, ChemTreat), product marking systems (Videojet, Linx), color management tools (X-Rite, Pantone), and packaging design software (Esko) for municipal utilities, industrial operations, and food and pharma customers.
What's Veralto's balance sheet position?
Veralto has $1.78B in cash against $3.12B in debt, with trailing gross margins of 59.8% and $763M in free cash flow, leaving room for buybacks or acquisitions.
Veralto Corporation posted its fourth consecutive quarterly EPS beat on October 29, with Q3 adjusted EPS of $1.18 beating the Wall Street consensus by 7.27% and revenue topping estimates for the third time in four quarters. The analyst consensus price target of $124.625 implies further upside — but the heads of both business segments sold shares in the two weeks following the report, and no executive made a single open-market purchase in the entire 90-day window.